பலப்படுத்துகிறது சமநிலை தாள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from பலப்படுத்துகிறது சமநிலை தாள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In பலப்படுத்துகிறது சமநிலை தாள் Today - Breaking & Trending Today

Valaris Successfully Completes Restructuring

Valaris Successfully Completes Restructuring
Improves Liquidity Position by Receiving $520M Capital Injection
Valaris Limited ( Valaris or the Company and together with its subsidiaries, the Valaris Group ) today announced that, on April 30, 2021, the Valaris Group has successfully completed its financial restructuring and emerged from chapter 11. The Valaris Group s Plan of Reorganization (the Plan ) was approved and confirmed by the United States Bankruptcy Court for the Southern District of Texas on March 3, 2021. Valaris now moves forward with a strengthened capital structure, eliminating $7.1B of debt and securing a $520M capital injection by issuing $550M of new secured notes maturing in 2028. As of April 30, 2021, Valaris had $615M of available cash, $40M of restricted cash and $550M of debt. ....

United States , United Kingdom , Elizabeth Leykum , Mark Granville Firmin , Joseph Goldschmid , Anton Dibowitz , Jonathan Charles Marston , Tom Burke , Dick Fagerstal , Deepak Munganahalli , Thomas Burke , Akin Gump Strauss Hauer Feld , Lazard Ltd , Kirkland Ellis , Valaris Limited , Stretto International , Shearman Sterling , Valaris Group Plan Of Reorganization The , Institute Of Chartered Accountants , York Stock Exchange , Securities Exchange Commission , Valaris Group , United States Bankruptcy Court , Alvarez Marsal North America , Houlihan Lokey Inc , New York Stock Exchange ,

US: Valaris successfully completes restructuring

US: Valaris successfully completes restructuring
03 May 2021
Improves Liquidity Position by Receiving $520 Million Capital Injection
Valaris, the industry leader in offshore drilling services across all water depths and geographies, has announced that, on April 30, 2021, the Valaris Group has successfully completed its financial restructuring and emerged from chapter 11. The Valaris Group s Plan of Reorganization was approved and confirmed by the United States Bankruptcy Court for the Southern District of Texas on March 3, 2021. Valaris now moves forward with a strengthened capital structure, eliminating $7.1 billion of debt and securing a $520 million capital injection by issuing $550 million of new secured notes maturing in 2028. As of April 30, 2021, Valaris had $615 million of available cash, $40 million of restricted cash and $550 million of debt. ....

United States , United Kingdom , Tom Burke , York Stock Exchange , Valaris Group Plan Of Reorganization , Valaris Group , New York Stock Exchange , United States Bankruptcy Court , Company Of The Valaris Group , Strengthens Balance Sheet , Liquidity Position , Southern District , Chief Executive Officer , Old Valaris , E Ampp News , Il And Gas Exploration , Xploration And Production , Nergy Pedia , Eological And Geophysical , Lternative Energy , Eavy Oil , Il And Gas Condensate , Icence Round , Il And Gas Ministry , Oil Companies , ஒன்றுபட்டது மாநிலங்களில் ,

Oncocyte Announces $25 Million Registered Offering

Oncocyte Announces $25 Million Registered Offering
Offering Led by Current Shareholder and Healthcare Investor, Pura Vida Investments, Substantially Increasing Its Holdings
Further Strengthens Balance Sheet to Support Ongoing Commercial and Development Activities across Cancer Care Continuum
IRVINE, Calif., Jan. 20, 2021 Oncocyte Corporation (NYSE American: OCX), a molecular diagnostics company with a mission to provide actionable answers at critical decision points across the cancer care continuum, today announced that it has entered into definitive agreements with its two largest institutional investors to purchase approximately $25 million of Oncocyte’s common shares in a registered offering priced at $3.424 per share (“at market”), which was the average of the last five closing prices. The lead investor in the offering, Pura Vida Investments, LLC, a fundamentally driven, healthcare-focused registered investment advisor, increases its ownership of Oncocyte f ....

United States , United Kingdom , Determa Mx , Ron Andrews , Pura Vida , Development Activities , Office Of Oncocyte , Company Determa , Oncocyte Corporation Form , Exchange Commission , Oncocyte Corporation , Phd Lifesci Communications , Investor Contact Bob Yedid Lifesci Advisors , Its Holdings , Pura Vida Investments , Offering Led , Current Shareholder , Healthcare Investor , Substantially Increasing Its , Strengthens Balance Sheet , Support Ongoing Commercial , Cancer Care , Broadwood Partners , Chief Executive Office , Managing Member , Contact Bob Yedid Lifesci Advisors ,